Eli Lilly and Company Extends Grip on U.S. Rights to Cymbalta

INDIANAPOLIS, July 6, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has met the United States Food and Drug Administration (FDA) requirements for pediatric exclusivity…
Read the full story: BioSpace.com Featured News